23.3 C
New York
Thursday, September 23, 2021

Brooklyn Immunotherapeutics Inc. (BTX) stock soared approx. 100% on Monday, April 5 without any CLUE

Brooklyn Immunotherapeutics Inc. (BTX) stock rallied on Monday, April 5, 2021. It gained 24.53% in the morning session and the momentum continued in the after-hours session and it further rises 75.16%.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Let’s try to find out the reason behind its Monday surge.

Reverse merger completion with NTN Buzztime

On March 26, 2021, Brooklyn ImmunoTherapeutics, announced the completion of the reverse merger with NTN Buzztime, Inc. Brooklyn’s common stock has started trading on the NYSE American Exchange under the ticker symbol “BTX” from March 26, 2021.

According to the agreement, Brooklyn ImmunoTherapeutics has merged with NTN Buzztime and became a wholly-owned subsidiary of NTN Buzztime. NTN Buzztime has changed its name to Brooklyn ImmunoTherapeutics

Let’s have a look at the recent available financial figures of NTN Buzztime. NTN Buzztime announced its financial results on November 13, 2020,  for the third quarter ended September 30, 2020. 

3Q 2020 financial highlights

  • For the third quarter 2020, total revenues were $1.5 million, up to $0.7 million (or 96%) sequentially as compared to the second quarter of 2020, but down from $4.6 million in the third quarter of 2019
  • operating expenses for the reported quarter were $2.9 million compared with $4.9 million in the third quarter of 2019.
  • NTN Buzztime suffered a net loss of 1.5 million, or $0.50 per share to common shareholders in Q3 2020 compared with $351,000, or $0.12 per share, in the prior-year third quarter.
  • As of September 30, 2020, NTN Buzztime had cash, cash equivalents, and unrestricted cash of $1.7 million.

Conclusion: As there is no recent news to justify the BTX stock gains, the BTX stock volatility suggests that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon.

About the company

Brooklyn ImmunoTherapeuticsis exploring opportunities to advance therapies using leading-edge gene editing/cell therapy technology through its option agreement with Factor Bioscience/Novellus. Brooklyn ImmunoTherapeutics headquarters, laboratories, and manufacturing facilities are located in the historic Brooklyn Army Terminal.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest Articles

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam

Get The Best Stocks To Trade Every Day!

Join now to get the Newsheater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.